Produktbeschreibung
AOD 9604: THE PEPTIDE THAT MAKES WEIGHT LOSS "EASY"
Fat-reducing preparation in capsule form
AOD 9604 is the orally administered form of a peptide derived from human growth hormone (HGH). The letters "AOD" stand for "Advanced Obesity Drug," which clearly indicates its purpose and mechanism of action: AOD 9604 significantly promotes the breakdown of body fat! It is well known that HGH has a pronounced lipolytic effect—it stimulates the body to release fatty acids from body fat stores, resulting in rapid weight loss. AOD 9604 does exactly the same: In a 12-week clinical trial, subjects who received AOD-9604 daily lost almost three times as much fat as the control group [1].
ESPECIALLY EFFECTIVE AT PROBLEM POINTS
Unlike true growth hormone, which causes a more or less uniform reduction in fat, AOD 9604 targets problem areas—those areas where body fat is particularly concentrated. In men, this is primarily the abdominal region and the area around the hips; in women, it is the buttocks and thighs. This peptide also has another advantage over HGH: it does not negatively affect insulin sensitivity. Animal studies have shown that the stimulation of lipolysis by AOD 9604 does not cause any of the side effects known from HGH treatments [2]. According to the "Journal of Endocrinology & Metabolism," the safety and tolerability profile of AOD 9604 is therefore very good [3].
ADVANTAGES OF AOD 9604 COMPARED TO OTHER FAT REDUCTION SUPPLEMENTS
AOD 9604 has clear advantages over commercially available fat burner products and HGH boosters:
- It contains no stimulating ingredients (ephedrine, caffeine, guarana, etc.) and therefore does not impair sleep.
- It contains no pungent substances (such as capsaicin) that can cause heartburn.
- Since AOD 9604 promotes fat loss without affecting insulin sensitivity, there is no risk of developing glucose intolerance or other metabolic disorders.
- Due to the HGH-like effect of AOD 9604, cartilage and connective tissue structures also benefit from AOD-9604 supplementation [4].
APPLICATION AND DOSAGE
NOTE: This product is not intended for human use. It is sold as an experimental substance and may only be used for research purposes.
- MA Valentino, JE Lin, SA Waldman (2010): “Central and peripheral molecular targets for antiobesity pharmacotherapy” ( https://pubmed.ncbi.nlm.nih.gov/20445536/ )
- FM Ng et al. (2000): “Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone” ( https://pubmed.ncbi.nlm.nih.gov/11146367/ )
- Jofem.org (20139: Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans ( https://jofem.org/index.php/jofem/article/view/157/194 )
- DR Kwon, GY Park (2015): Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model ( https://pubmed.ncbi.nlm.nih.gov/26275694/ )